Physician profile
Anthony Shaya
NPI 1619931797
$6,125.45
in general payments reported to CMS, 2019-2025
36 companies · $2,596 in 2025
The $2,596 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $106 · 2021: $56.18 · 2022: $480 · 2023: $1,271 · 2024: $812 · 2025: $2,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,667 · Education: $1,000 · Travel and Lodging: $837 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,667.36 |
| Education | $1,000.00 |
| Travel and Lodging | $837.35 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,883.22 | 2025 | |
| Mayne Pharma Commercial LLC | $622.93 | 2021-2025 | |
| Shield Therapeutics INC | $443.53 | 2023-2025 | Accrufer |
| Amgen INC. | $440.16 | 2019-2025 | Prolia, Evenity, Prolia |
| Astellas Pharma US INC | $333.94 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $318.97 | 2019-2024 | Lo Loestrin Fe, Orilissa, Oriahnn |
| Hologic Sales and Service, LLC | $243.39 | 2019-2024 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $231.48 | 2019-2022 | |
| Myriad Women'S Health, INC. | $211.33 | 2023 | Myrisk |
| Allergan, INC. | $201.09 | 2019-2020 | |
| Pfizer INC. | $154.55 | 2022-2024 | |
| Coopersurgical, INC. | $143.99 | 2019-2024 | Paragard T 380a, Paragard T 380a, Wallach Cryosurgical Equipment |
| Bayer Healthcare Pharmaceuticals INC. | $133.13 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $113.10 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $79.86 | 2022-2023 | Slynd |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $67.46 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $58.07 | 2019-2023 | Gardasil 9 |
| Millicent US INC | $54.27 | 2025 | Femlyv, Intrarosa, Femring |
| Amag Pharmaceuticals, INC. | $51.47 | 2019 | |
| Organon LLC | $47.10 | 2022-2025 | |
| Avion Pharmaceuticals | $39.55 | 2019-2023 | Balcoltra |
| Pacira Pharmaceuticals Incorporated | $36.29 | 2022-2024 | Exparel |
| Biogen, INC. | $34.87 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $24.13 | 2022 | |
| Optumhealth Care Solutions, LLC | $21.69 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Mallinckrodt Enterprises LLC | $21.37 | 2019 | |
| Scynexis, INC. | $21.18 | 2022 | |
| Roche Diagnostics Corporation | $17.30 | 2019 | |
| Duchesnay USA Incorporated | $16.39 | 2019 | |
| Smith+Nephew, INC. | $15.91 | 2024 | Pico, Pico 14 |
| Ethicon US, LLC | $15.54 | 2025 | Dermabond Prineo, Vistaseal, Ethicon |
| Daiichi Sankyo INC. | $14.82 | 2024 | Injectafer |
| Teleflex LLC | $13.37 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Shaya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.